• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s digital health regulatory framework for SaMD – Cisema article featured on RAPS Weekly

China’s digital health regulatory framework for SaMD – Cisema article featured on RAPS Weekly

China's digital health regulatory framework
Monday, 12 December 2022 / Published in Medical Device, News, NMPA Registration in China

China’s digital health regulatory framework for SaMD – Cisema article featured on RAPS Weekly

China’s digital health regulatory framework for software as medical device (SaMD) has continuously been evolving with several important legislative developments over the years overseen by the China National Medical Products Administration (NMPA).

Hamish King, COO at Cisema, wrote an article recently on China’s digital health regulatory framework for SaMD for featuring on the weekly newsletter of the Regulatory Affairs Professionals Society (RAPS). The article is based on a presentation conducted by Hamish at the RAPS 2022 Convergence in Phoenix, Arizona during September 11-13, 2022. As a RAPS member and also certified by RAPS with the RAC qualification, Hamish actively presents in seminars and webinars for RAPS and other global exhibitions or trade fair events such as MEDICA in Messe Dusseldorf.

About RAPS

RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC) credentials, the only post-academic professional certifications to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide.

Further Information

Click here to read the article on China’s digital health regulatory framework for SaMD.

Or if you are a member of RAPS, you may click here to read the original article featured on RAPS.

Focusing on latest regulatory hot topics and developments in China, Cisema annually presents over 70 public seminars, webinars, trainings and workshops for clients and industry in association with government, export agencies, seminar providers, conferences, trade associations and partners. Feel free to contact us if you are interested to carry out an in-house seminar with our regulatory specialists tailored to your requirements.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

Public Consultation on the Measures of Review Management on Advertising for Health Food, FSMP, Drug Products and Medical Devices
Regulatory Updates for Implant Products in September 2021
Radio Frequency Beauty Devices will be regulated as Medical Devices Soon

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...
  • China medical device quality safety responsibility

    China medical device quality and safety responsibility regulations come into force on March 1, 2023

    China medical device quality and safety respons...
  • China drug standards draft measures

    China drug standards draft measures have been published by the NMPA

    China drug standards draft measures have recent...
  • China special equipment safety supervision

    China special equipment safety supervision – draft provisions released

    China special equipment safety supervision regu...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.